Patient Dies by Suicide After ‘Insurance Issue’ Delayed Medicine for Lung Disease Flare-Ups
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 trends tracked about this subject — the full history, oldest to newest below.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
AstraZeneca reports positive Phase III trial results for tozorakimab, a drug targeting COPD exacerbations.
AstraZeneca and Sanofi detail new respiratory clinical data at the #ERS26 conference.
AstraZeneca reports significant Phase III trial wins for Tozorakimab, a COPD drug showing broad benefits for current and former smokers.
New clinical trial data suggests deliberate laughter therapy can match standard breathing exercises in easing breathlessness for COPD patients.